{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:50:10Z","timestamp":1759960210560},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Correction of barrier dysfunction and inflammation in acute lung injury (ALI) represents an important problem. Previous studies demonstrate barrier-protective and anti-inflammatory effects of bioactive lipid prostacyclin and its stable analog iloprost (ILO). We generated a phospholipase resistant synthetic phospholipid with iloprost attached at the <jats:italic>sn<\/jats:italic>-2 position (ILO-PC) and investigated its biological effects. In comparison to free ILO, ILO-PC caused sustained endothelial cell (EC) barrier enhancement, linked to more prolonged activation of Rap1 and Rac1 GTPases and their cytoskeletal and cell junction effectors: cortactin, PAK1, p120-catenin and VE-cadherin. ILO and ILO-PC equally efficiently suppressed acute, Rho GTPase-dependent EC hyper-permeability caused by thrombin. However, ILO-PC exhibited more sustained barrier-protective and anti-inflammatory effects in the model of chronic EC dysfunction caused by bacterial wall lipopolysacharide (LPS). ILO-PC was also more potent inhibitor of NF\u03baB signaling and lung vascular leak in the murine model of LPS-induced ALI. Treatment with ILO-PC showed more efficient ALI recovery over 3 days after LPS challenge than free ILO. In conclusion, this study describes a novel synthetic phospholipid with barrier-enhancing and anti-inflammatory properties superior to existing prostacyclin analogs, which may be used as a prototype for future development of more efficient treatment for ALI and other vascular leak syndromes.<\/jats:p>","DOI":"10.1038\/s41598-018-19197-1","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T10:17:24Z","timestamp":1515665844000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Incorporation of iloprost in phospholipase-resistant phospholipid scaffold enhances its barrier protective effects on pulmonary endothelium"],"prefix":"10.1038","volume":"8","author":[{"given":"Olga","family":"Oskolkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolene","family":"Sarich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Gawlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanyong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery N.","family":"Bochkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Berdyshev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna A.","family":"Birukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin G.","family":"Birukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"19197_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.biocel.2003.08.006","volume":"36","author":"CL Bos","year":"2004","unstructured":"Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P. & Versteeg, H. H. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36, 1187\u20131205 (2004).","journal-title":"Int J Biochem Cell Biol"},{"key":"19197_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00003495-200262010-00005","volume":"62","author":"EB Melian","year":"2002","unstructured":"Melian, E. B. & Goa, K. L. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension. Drugs 62, 107\u2013133 (2002).","journal-title":"Drugs"},{"key":"19197_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00418-008-0422-y","volume":"129","author":"Y Baumer","year":"2008","unstructured":"Baumer, Y., Drenckhahn, D. & Waschke, J. cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium. Histochem Cell Biol 129, 765\u2013778 (2008).","journal-title":"Histochem Cell Biol"},{"key":"19197_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/MCB.25.1.136-146.2005","volume":"25","author":"S Fukuhara","year":"2005","unstructured":"Fukuhara, S. et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25, 136\u2013146 (2005).","journal-title":"Mol Cell Biol"},{"key":"19197_CR5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.yexcr.2007.03.036","volume":"313","author":"AA Birukova","year":"2007","unstructured":"Birukova, A. A. et al. Prostaglandins PGE2 and PGI2 promote endothelial barrier enhancement via PKA- and Epac1\/Rap1-dependent Rac activation. Exp Cell Res 313, 2504\u20132520 (2007).","journal-title":"Exp Cell Res"},{"key":"19197_CR6","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1152\/japplphysiol.00462.2009","volume":"107","author":"AA Birukova","year":"2009","unstructured":"Birukova, A. A., Fu, P., Xing, J. & Birukov, K. G. Rap1 mediates protective effects of iloprost against ventilator induced lung injury. J Appl Physiol 107, 1900\u20131910 (2009).","journal-title":"J Appl Physiol"},{"key":"19197_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trsl.2009.09.002","volume":"155","author":"AA Birukova","year":"2010","unstructured":"Birukova, A. A., Fu, P., Xing, J., Cokic, I. & Birukov, K. G. Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling. Transl Res 155, 44\u201354 (2010).","journal-title":"Transl Res"},{"key":"19197_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1183\/09031936.00148311","volume":"41","author":"AA Birukova","year":"2013","unstructured":"Birukova, A. A. et al. Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur Respir J 41, 165\u2013176 (2013).","journal-title":"Eur Respir J"},{"key":"19197_CR9","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1016\/j.febslet.2005.07.080","volume":"579","author":"MR Kooistra","year":"2005","unstructured":"Kooistra, M. R., Corada, M., Dejana, E. & Bos, J. L. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579, 4966\u20134972 (2005).","journal-title":"FEBS Lett"},{"key":"19197_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.bbadis.2014.12.016","volume":"1852","author":"AA Birukova","year":"2015","unstructured":"Birukova, A. A. et al. Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1. Biochim Biophys Acta 1852, 778\u2013791 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"19197_CR11","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.4049\/jimmunol.164.12.6543","volume":"164","author":"M Essler","year":"2000","unstructured":"Essler, M., Staddon, J. M., Weber, P. C. & Aepfelbacher, M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho\/Rho kinase signaling [In Process Citation]. J Immunol 164, 6543\u20136549 (2000).","journal-title":"J Immunol"},{"key":"19197_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.RES.0000147310.18962.06","volume":"95","author":"KG Birukov","year":"2004","unstructured":"Birukov, K. G. et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 95, 892\u2013901 (2004).","journal-title":"Circ Res"},{"key":"19197_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.trsl.2012.12.008","volume":"161","author":"AA Birukova","year":"2013","unstructured":"Birukova, A. A. et al. Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC. Transl Res 161, 495\u2013504 (2013).","journal-title":"Transl Res"},{"key":"19197_CR14","first-page":"02014","volume":"00248","author":"A Meliton","year":"2015","unstructured":"Meliton, A. et al. Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus. Am J Physiol Lung Cell Mol Physiol, ajplung 00248, 02014 (2015).","journal-title":"Am J Physiol Lung Cell Mol Physiol, ajplung"},{"key":"19197_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00192562","volume":"46","author":"W Cawello","year":"1994","unstructured":"Cawello, W., Schweer, H., Muller, R., Bonn, R. & Seyberth, H. W. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. European journal of clinical pharmacology 46, 275\u2013277 (1994).","journal-title":"European journal of clinical pharmacology"},{"key":"19197_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s002280050336","volume":"53","author":"M Hildebrand","year":"1997","unstructured":"Hildebrand, M. Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients. European journal of clinical pharmacology 53, 51\u201356 (1997).","journal-title":"European journal of clinical pharmacology"},{"key":"19197_CR17","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.bbamem.2012.03.004","volume":"1818","author":"TM McIntyre","year":"2012","unstructured":"McIntyre, T. M. Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation. Biochim Biophys Acta 1818, 2456\u20132464 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"19197_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.bbamem.2008.12.010","volume":"1788","author":"WJ Pannekoek","year":"2009","unstructured":"Pannekoek, W. J., Kooistra, M. R., Zwartkruis, F. J. & Bos, J. L. Cell-cell junction formation: The role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim Biophys Acta 1788, 790\u2013796 (2009).","journal-title":"Biochim Biophys Acta"},{"key":"19197_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","volume":"72","author":"GM Bokoch","year":"2003","unstructured":"Bokoch, G. M. Biology of the p21-Activated Kinases. Annu Rev Biochem 72, 743\u2013781 (2003).","journal-title":"Annu Rev Biochem"},{"key":"19197_CR20","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1091\/mbc.E02-11-0753","volume":"14","author":"JA Head","year":"2003","unstructured":"Head, J. A. et al. Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell 14, 3216\u20133229 (2003).","journal-title":"Mol Biol Cell"},{"key":"19197_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-008-0694-5","volume":"335","author":"E Dejana","year":"2009","unstructured":"Dejana, E., Orsenigo, F., Molendini, C., Baluk, P. & McDonald, D. M. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 335, 17\u201325 (2009).","journal-title":"Cell Tissue Res"},{"key":"19197_CR22","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1091\/mbc.E13-02-0098","volume":"24","author":"AA Birukova","year":"2013","unstructured":"Birukova, A. A., Tian, X., Tian, Y., Higginbotham, K. & Birukov, K. G. Rap-afadin axis in control of Rho signaling and endothelial barrier recovery. Mol Biol Cell 24, 2678\u20132688 (2013).","journal-title":"Mol Biol Cell"},{"key":"19197_CR23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/jbc.M511248200","volume":"281","author":"M Holinstat","year":"2006","unstructured":"Holinstat, M. et al. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 281, 2296\u20132305 (2006).","journal-title":"J Biol Chem"},{"key":"19197_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/01.RES.87.4.335","volume":"87","author":"GP van Nieuw Amerongen","year":"2000","unstructured":"van Nieuw Amerongen, G. P., van Delft, S., Vermeer, M. A., Collard, J. G. & van Hinsbergh, V. W. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 87, 335\u2013340 (2000).","journal-title":"Circ Res"},{"key":"19197_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2613.2007.00566.x","volume":"88","author":"D Togbe","year":"2007","unstructured":"Togbe, D. et al. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol 88, 387\u2013391 (2007).","journal-title":"Int J Exp Pathol"},{"key":"19197_CR26","doi-asserted-by":"publisher","first-page":"26278","DOI":"10.1074\/jbc.M414467200","volume":"280","author":"UK Misra","year":"2005","unstructured":"Misra, U. K., Deedwania, R. & Pizzo, S. V. Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J Biol Chem 280, 26278\u201326286 (2005).","journal-title":"J Biol Chem"},{"key":"19197_CR27","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1091\/mbc.E13-12-0743","volume":"25","author":"AA Birukova","year":"2014","unstructured":"Birukova, A. A. et al. GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids. Mol Biol Cell 25, 2006\u20132016 (2014).","journal-title":"Mol Biol Cell"},{"key":"19197_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood.V99.1.199","volume":"99","author":"VN Bochkov","year":"2002","unstructured":"Bochkov, V. N. et al. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK\/EGR-1 and Ca(++)\/NFAT. Blood 99, 199\u2013206 (2002).","journal-title":"Blood"},{"key":"19197_CR29","doi-asserted-by":"publisher","first-page":"12010","DOI":"10.1073\/pnas.96.21.12010","volume":"96","author":"N Leitinger","year":"1999","unstructured":"Leitinger, N. et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci USA 96, 12010\u201312015 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"19197_CR30","doi-asserted-by":"publisher","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","volume":"272","author":"AD Watson","year":"1997","unstructured":"Watson, A. D. et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272, 13597\u201313607 (1997).","journal-title":"J Biol Chem"},{"key":"19197_CR31","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1016\/S0040-4020(99)00551-7","volume":"55","author":"OV Oskolkova","year":"1999","unstructured":"Oskolkova, O. V., Watanabe, Y. & Nakatomi, M. Synthesis of PI(3,4,5)P-3 with unsaturated and saturated fatty acid chains. Tetrahedron 55, 9743\u20139754 (1999).","journal-title":"Tetrahedron"},{"key":"19197_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0005-2760(68)90038-6","volume":"152","author":"RM Broekhuyse","year":"1968","unstructured":"Broekhuyse, R. M. Phospholipids in tissues of the eye. I. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids. Biochim Biophys Acta 152, 307\u2013315 (1968).","journal-title":"Biochim Biophys Acta"},{"key":"19197_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology 37, 911\u2013917 (1959).","journal-title":"Canadian journal of biochemistry and physiology"},{"key":"19197_CR34","doi-asserted-by":"publisher","first-page":"L540","DOI":"10.1152\/ajplung.00259.2005","volume":"290","author":"AA Birukova","year":"2006","unstructured":"Birukova, A. A. et al. GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 290, L540\u2013548 (2006).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"19197_CR35","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1096\/fj.04-2328com","volume":"18","author":"AA Birukova","year":"2004","unstructured":"Birukova, A. A. et al. Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J 18, 1879\u20131890 (2004).","journal-title":"FASEB J"},{"key":"19197_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/labinvest.2012.159","volume":"93","author":"O Dubrovskyi","year":"2013","unstructured":"Dubrovskyi, O., Birukova, A. A. & Birukov, K. G. Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury. Lab Invest 93, 254\u2013263 (2013).","journal-title":"Lab Invest"},{"key":"19197_CR37","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1074\/jbc.M114.620377","volume":"290","author":"Y Tian","year":"2015","unstructured":"Tian, Y. et al. Hepatocyte growth factor-induced Asef-IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier. J Biol Chem 290, 4097\u20134109 (2015).","journal-title":"J Biol Chem"},{"key":"19197_CR38","doi-asserted-by":"publisher","first-page":"L199","DOI":"10.1152\/ajplung.00020.2007","volume":"293","author":"AA Birukova","year":"2007","unstructured":"Birukova, A. A., Malyukova, I., Poroyko, V. & Birukov, K. G. Paxillin - {beta}-catenin interactions are involved in Rac\/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 293, L199\u2013211 (2007).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"19197_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1183\/09031936.00014808","volume":"33","author":"P Fu","year":"2009","unstructured":"Fu, P. et al. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J 33, 612\u2013624 (2009).","journal-title":"Eur Respir J"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:58:27Z","timestamp":1671584307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19197"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19197-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"30 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"879"}}